Indianapolis, IN, United States of America

Joshua Zwick Davison

This inventor holds 1 USPTO granted patent. Top assignee: Eli Lilly and Company. Active years: 2005.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Joshua Zwick Davison. Retrieved from https://idiyas.com/inventor/joshua-zwick-davison

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2005

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Joshua Zwick Davison

Introduction

Joshua Zwick Davison is an accomplished inventor based in Indianapolis, IN. He has made significant contributions to the field of pharmaceuticals, particularly in the development of sulfonamide derivatives. His work focuses on enhancing glutamate receptor function, which has implications for treating various psychiatric and neurological disorders.

Latest Patents

Joshua Zwick Davison holds a patent for sulfonamide derivatives. This invention provides certain sulfonamide derivatives that are useful for potentiating glutamate receptor function in patients. The potential applications of this invention are vast, as it can aid in the treatment of a wide variety of conditions, including psychiatric and neurological disorders.

Career Highlights

Joshua is currently employed at Eli Lilly and Company, a leading global pharmaceutical company. His role involves research and development in innovative therapeutic solutions. His expertise and dedication have contributed to advancements in medical treatments.

Collaborations

Throughout his career, Joshua has collaborated with notable colleagues, including Winton Dennis Jones, Jr. and Hamideh Zarrinmayeh. These collaborations have fostered a productive environment for innovation and research.

Conclusion

Joshua Zwick Davison's contributions to the field of pharmaceuticals through his patent on sulfonamide derivatives highlight his commitment to advancing medical science. His work continues to pave the way for new treatments for complex disorders.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…